Breaking News
Get 50% Off 0
Q4 Earnings Alert! Plan ahead with key data on upcoming stock reports - all in 1 place
See Calendar
Close

Uniinstitutional European Minrisk Equities (0P00001C1H)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
87.530 -0.270    -0.31%
14/01 - Closed. Currency in EUR
Type:  Fund
Market:  Germany
ISIN:  DE0009750554 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 369.89M
UniInstitutional European MinRisk Equities 87.530 -0.270 -0.31%

0P00001C1H Holdings

 
Comprehensive information about top holdings and Key Holding Information for the UniInstitutional European MinRisk Equities (0P00001C1H) fund. Our UniInstitutional European MinRisk Equities portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 0.080 0.080 0.000
Shares 99.920 99.920 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 14.981 14.191
Price to Book 2.342 2.050
Price to Sales 1.325 1.418
Price to Cash Flow 9.013 9.423
Dividend Yield 3.504 3.417
5 Years Earnings Growth 8.063 10.091

Sector Allocation

Name  Net % Category Average
Healthcare 26.050 14.850
Consumer Defensive 15.610 10.911
Industrials 14.220 16.750
Communication Services 11.960 5.274
Financial Services 10.080 18.273
Technology 8.850 9.161
Energy 5.550 4.531
Consumer Cyclical 3.340 9.918
Utilities 2.300 4.575
Basic Materials 1.130 6.550
Real Estate 0.900 1.953

Region Allocation

  • North America
  • Europe Developed
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 114

Number of short holdings: 0

Name ISIN Weight % Last Change %
  Novo Nordisk B DK0062498333 4.93 605.0 +2.14%
  SAP DE0007164600 3.24 253.600 +2.51%
  Novartis CH0012005267 3.17 90.60 +0.54%
  Roche Holding Participation CH0012032048 3.07 265.90 +0.95%
  Nestle CH0038863350 2.73 73.66 -0.67%
  AstraZeneca GB0009895292 2.71 10,648.0 +0.17%
QFS SICAV - European Eqs EUR I dis LU1120174377 2.62 - -
  Sanofi FR0000120578 2.27 95.82 +2.77%
  TotalEnergies SE FR0000120271 2.26 55.93 +0.59%
  ABB CH0012221716 2.25 49.60 +1.33%

Top Equity Funds by Union Investment Privatfonds GmbH

  Name Rating Total Assets YTD% 3Y% 10Y%
  UniGlobal Vorsorge 23.08B 17.94 4.45 -
  UniGlobal 20.3B 26.92 10.89 12.04
  UniGlobal I 20.3B 25.40 9.32 12.24
  PrivatFonds: Kontrolliert 15.56B 10.42 0.53 1.65
  UniFavorit: Aktien 13.19B 31.31 11.60 11.74
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P00001C1H Comments

Write your thoughts about Uniinstitutional European Minrisk Equities
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email